Partnership Expansion OncoDNA has recently expanded its partnerships with companies like Lilly, SYNLAB, and Synlab Vet, indicating a growing network and potential for collaboration in providing biomarker testing services.

Kit Launch Success The successful launch of OncoDNA's OncoDeep kit, integrating reagents and quality control standards for sequencing over 600 cancer biomarkers, showcases the company's innovative solutions that can be leveraged as valuable tools for oncologists seeking personalized treatment options.

International Presence With entities based in Belgium, France, and Spain, and collaborations with accredited laboratories globally, OncoDNA has established a strong international presence, offering potential opportunities for cross-border sales and partnerships in precision oncology.

Research Initiatives OncoDNA's involvement in research projects with prestigious institutions like Institut Curie highlights the company's commitment to driving advancements in precision medicine, creating potential avenues for sales through cutting-edge research-driven solutions.

Competitive Edge While competing with companies like Genomic Health and Guardant Health, OncoDNA's unique focus on theranostics, comprehensive biomarker testing, and NGS data interpretation services positions it as an attractive partner for oncologists and biopharmaceutical companies seeking personalized cancer treatment solutions.